Immediate Impact
2 from Science/Nature 87 standout
Citing Papers
Tackling the emerging threat of antifungal resistance to human health
2022 Standout
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
2021 Standout
Works of W. von Sinner being referenced
An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive Aspergillosis
1998
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| W. von Sinner | 154 | 163 | 217 | 203 | 13 | 478 | |
| N. Mariniello | 247 | 143 | 148 | 130 | 18 | 507 | |
| Raúl A. Marcial-Rojas | 188 | 73 | 61 | 55 | 25 | 550 | |
| James T. Albright | 140 | 60 | 71 | 136 | 20 | 462 | |
| Alejandro Gómez-Delgado | 122 | 25 | 111 | 126 | 20 | 470 | |
| J. M. Wolfe | 104 | 83 | 187 | 230 | 21 | 416 | |
| R Du Toit | 72 | 38 | 88 | 87 | 28 | 426 | |
| Chris Johnston | 209 | 24 | 71 | 58 | 22 | 561 | |
| Saul Rodriguez | 61 | 17 | 140 | 122 | 10 | 488 | |
| Daniela Carli Buttenschoen | 281 | 190 | 70 | 52 | 14 | 414 | |
| J N Harcourt-Webster | 95 | 20 | 95 | 180 | 26 | 412 |
All Works
Loading papers...